SOURCE: Dynavax Technologies

Dynavax Technologies

October 20, 2010 16:01 ET

Dynavax to Present at the BioCentury NewsMakers Conference

BERKELEY, CA--(Marketwire - October 20, 2010) - Dynavax Technologies Corporation (NASDAQ: DVAX) announced today that it plans to present at the BioCentury NewsMakers in the Biotech Industry conference on Friday, October 22, 2010 at the Millennium Hotel in New York City, NY.

Michael Ostrach, Chief Business Officer, will provide a corporate overview at 11:00 am Eastern Time (8:00 am Pacific Time).

About Dynavax
Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops novel products to prevent and treat infectious diseases. The Company's lead product candidate is HEPLISAV™, a Phase 3 investigational adult hepatitis B vaccine designed to provide more rapid and increased protection with fewer doses than current licensed vaccines. For more information visit

Contact Information

  • Contact:
    Shari Annes
    Investor Relations
    Email Contact